Consultations

You are here

AVIS D'ATTRIBUTION PROVISOIRE CONSULTATION N°05-MED2024 - ACIDE TRANEXAMIQUE INJ 500MG-5ML

by communication / 12 Mar, 2024

AVIS DE PROROGATION - CONSULTATION N°17-MED-2024 - LAMIVUDINE 150MG COMP

by communication / 12 Mar, 2024

AVIS DE PROROGATION - CONSULTATION N°18-MED-2024 - NEVIRAPINE SUSP BUV 50MG-5ML

by communication / 12 Mar, 2024

AVIS DE PROROGATION 2 - CONSULTATION N°07-MED-2024 HYDORCORTISONE HEMISUCCINATE INJ 500MG

by communication / 12 Mar, 2024

AVIS DE PROROGATION CONSULTATION N°15-MED-2024 - PRALIDOXIME INJ 200MG

by communication / 11 Mar, 2024

AVIS DE PROROGATION CONSULTATION N°14-MED-2024 - BROMHEXINE CHL INJ 4MG-2ML

by communication / 11 Mar, 2024

AVIS DE CONSULTATION N°22-MED-2024 - SALBUTAMOL INJ IV 0.5MG-ML

by communication / 10 Mar, 2024

AVIS DE CONSULTATION N°21-MED-2024 - HUILE DE PARAFFINE LIQ

by communication / 05 Mar, 2024

AVIS DE CONSULTATION N°20-MED-2024 - SOMATROPINE INJ 4UI (1.33MG-ML)

by communication / 05 Mar, 2024

AVIS DE PROROGATION CONSULTATION N°06/MED/2024 CLADRIBINE 1MG/ML SOL P/PERF F/10ML

by communication / 04 Mar, 2024

Pages

09789332719.png